HXHaikun Xu

Haikun Xu

*This is an algorithmically generated author record based on publicly available information.

Haikun Xu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dietary inflammatory index and body shape index and mortality risk in early-stage cardiovascular–kidney–metabolic syndrome: evidence from NHANES

    by Yihan Wang, Yue Qiao, Wei Wang, Yunhai Mao, Wenchao Wang, Haikun Xu, Mengchao Zhang

    Background: Cardiovascular-kidney-metabolic (CKM) syndrome is a newly recognized multisystem disorder encompassing metabolic dysfunction, chronic kidney disease, and cardiovascular disease, with most individuals remaining in early stages (0–3). Chronic inflammation and abnormal adipose tissue distribution are central to CKM pathogenesis; however, the prognostic relevance of diet-related inflammatory exposure in combination with body shape–derived central adiposity during this early stage remains unclear. Methods: Data were derived from the National Health and Nutrition Examination Survey (NHANES) 2001–2018, including 32,976 adults with early-stage CKM syndrome. Dietary inflammatory potential was assessed using the Dietary Inflammatory Index (DII), calculated from dietary intake collected during the first 24-hour dietary recall in the primary analysis. In the sensitivity analysis restricted to participants from the 2003–2018 survey cycles with two valid 24-hour dietary recalls, the mean of the Day 1 and Day 2 recall-specific DII scores was used. Central adiposity was evaluated using A Body Shape Index (ABSI). All-cause mortality was the primary outcome, and cardiovascular disease (CVD) mortality was the secondary outcome. Multivariable Cox proportional hazards models were applied to examine independent and joint associations, with subgroup and sensitivity analyses conducted to assess robustness. Results: During a mean follow-up of 102.5 months, 3,690 deaths occurred, including 1,004 due to CVD. Higher DII and ABSI were independently associated with increased all-cause mortality, while ABSI was also positively associated with CVD mortality. Notably, individuals with a dual high-risk profile—characterized by concomitantly high DII and high ABSI—exhibited the highest risks of both all-cause and CVD mortality. These associations appeared to be more pronounced among older adults, women, individuals with obesity, non-Hispanic White participants, and those with hypertension. In the repeated-recall sensitivity analysis, concomitantly high DII and high ABSI remained significantly associated with both all-cause and cardiovascular mortality, whereas high DII was significantly associated with cardiovascular mortality but not with all-cause mortality. Conclusions: This study provides novel population-based evidence that concomitantly high dietary inflammatory potential and central adiposity are associated with increased risks of both all-cause and cardiovascular mortality among adults with early-stage CKM syndrome, with these joint associations remaining statistically significant in the repeated-recall analysis. Although the DII-specific association with all-cause mortality was less consistent across dietary assessment approaches, the joint assessment of DII and ABSI may provide complementary information for mortality risk stratification in early-stage CKM syndrome.

  • Diabetes, glycemic control and arterial stiffness: a real-world cohort study in the context of predictive, preventive, and personalized medicine

    by Cancan Cui, Te Zhang, Yitian Qi, Jiaqi Chu, Haikun Xu, Chen Sun, Zhenming Zhang, Xingang Wang, Siqi Yue, Xiaoping Kang, et al.

    Background Arterial stiffness is a major contributor to morbidity and mortality worldwide. Although several metabolic markers associated with arterial stiffness have been developed, there is limited data regarding whether glycemic control modifies the association between diabetes and arterial stiffness. For these reasons, identification of traits around diabetes will directly contribute to arterial stiffness and atherosclerosis management in the context of predictive, preventive, and personalized medicine (PPPM). Thus, this study aimed to explore the relationship of diabetes and glycemic control status with arterial stiffness in a real-world setting. Methods Data of participants from Beijing Xiaotangshan Examination Center (BXEC) with at least two surveys between 2008 and 2019 were used. Cumulative hazards were presented by inverse probability of treatment weighted (IPTW) Kaplan-Meier curves. Cox models were used to estimate the hazard ratio (HR) and 95% confidence interval (CI). Arterial stiffness was defined as brachial-ankle pulse wave velocity (baPWV) ≥1400 cm/s. Results Of 5837 participants, the mean baseline age was 46.5±9.3 years, including 3791 (64.9%) males. During a median follow-up of 4.0 years, 1928 (33.0%) cases of incident arterial stiffness were observed. People with diabetes at baseline had a 48.4% (HR: 1.484, 95% CI: 1.250–1.761) excessive risk of arterial stiffness. Adherence to good glycemic control attenuated the relationship between diabetes and arterial stiffness (HR: 1.264, 95% CI: 0.950–1.681); while uncontrolled diabetes was associated with the highest risk of arterial stiffness (HR: 1.629, 95% CI: 1.323–2.005). Results were consistent using IPTW algorithm and multiple imputed data. Conclusion Our study quantified that diabetes status is closely associated with an increased risk of arterial stiffness and supported that adherence to good glycemic control could attenuate the adverse effect of diabetes on arterial stiffness. Therefore, glucose monitoring and control is a cost-effective strategy for the predictive diagnostics, targeted prevention, patient stratification, and personalization of medical services in early vascular damages and arterial stiffness.